Bladder cancer Quality Performance Indicators
Patients diagnosed between April 2017 and March 2020

About this release

This release by Public Health Scotland (PHS) presents performance against the National Bladder Cancer Quality Performance Indicators (QPIs) in the Cancer QPIs dashboard held within the Scottish Cancer Registry and Intelligence Service (SCRIS).

Main points

• There were 1,460 patients diagnosed with bladder cancer in Scotland over the period April 2019 to March 2020. This is a slight increase from the previous years (1,434 and 1,452 patients diagnosed in April 2017 to March 2018 and April 2018 to March 2019, respectively).
• At Scotland level for April 2019 to March 2020, the target was met in eight of the 21 indicators (see Table 1).
• Some of the QPI targets set have proved challenging to achieve and there remains room for further service improvement. However, it is encouraging that targets relating to MDT discussion and lymph node yield were consistently met. The results for QPI 11 also indicate good performance in relation to 30 and 90 day mortality rates (see Table 1).
• QPI 8: Volume of cases per surgeon, is not presented on the dashboard and the main points are:
• Between April 2019 and March 2020, 16 surgeons performed cystectomies in Scotland and of those, seven performed 10+ that year.
• Between April 2018 and March 2019, 18 surgeons performed cystectomies in Scotland and of those, seven performed 10+ that year.
• Between April 2017 and March 2018, 28 surgeons performed cystectomies in Scotland and of those, six performed 10+ that year.

NHS Scotland performance against bladder cancer quality performance indicators for Oct 17 - Sep 18 to Oct 19 - Sep 20. QPI 1 part 1 : 95% target met throughout. QPI 1 part 2 : This QPI was not recorded in Oct 17 - Sep 18, 95% target not met in Oct 18 - Sep 19 and met in Oct 19 - Sep 20. QPI 2 part 1 : 95% target not met throughout. QPI 2 part 2 : 95% target not met in Oct 17 - Sep 18, met in Oct 18 - Sep 19 and not met in Oct 19 - Sep 20. QPI 2 part 3 : This QPI was not recorded in Oct 17 - Sep 18. 80% target met in Oct 18 - Sep 19 and not met in Oct 19 - Sep 20. QPI 3 : 60% target met in Oct 17 - Sep 18, met in Oct 18 - Sep 19 and not met in Oct 19 - Sep 20. QPI 4 part 1 : This QPI was not recorded in Oct 17 - Sep 18. 80% target not met in Oct 18 - Sep 19 and not met in Oct 19 - Sep 20. QPI 4 part 2 : This QPI was not recorded in Oct 17 - Sep 18. 80% target not met in Oct 18 - Sep 19 and not met in Oct 19 - Sep 20. QPI 4 part 3 : This QPI was not recorded in Oct 17 - Sep 18. 80% target not met in Oct 18 - Sep 19 and not met in Oct 19 - Sep 20. QPI 5 part 1 : 90% target met throughout. QPI 5 part 2 : 90% target met throughout. QPI 6 : This QPI was not recorded in Oct 17 - Sep 18. 90% target met in Oct 18 - Sep 19 and met in Oct 19 - Sep 20. QPI 7 part 1 : 90% target not met throughout. QPI 7 part 2 : 90% target not met throughout. QPI 9 : 60% target met in Oct 17 - Sep 18, not met in Oct 18 - Sep 19 and not met in Oct 19 - Sep 20. QPI 10 : 50% target not met throughout. QPI 11 part 1 – 30-day mortality – <3% target met throughout. QPI 11 part 1 – 90-day mortality – <5% target met throughout. QPI 11 part 2 – 30-day mortality – <3% target met throughout. QPI 11 part 2 – 90-day mortality – <5% target met in Oct 17 - Sep 18, met in Oct 18 - Sep 19 and not met in Oct 19 - Sep 20. QPI 11 part 3 – 30-day mortality – <3% target not met in Oct 17 - Sep 18. This QPI was not recorded in Oct 18 - Sep 19 or Oct 19 - Sep 20. QPI 11 part 3 – 90-day mortality – <5% target met in Oct 17 - Sep 18. This QPI was not recorded in Oct 18 - Sep 19 or Oct 19 - Sep 20. QPI 12 : 15% target not met throughout.

Close

Table 1: Bladder QPIs summary

Background

National cancer quality performance indicators have been developed to support continuous quality improvement in cancer care. NHS Boards are required to report these indicators against a clinically agreed indicator specific target as part of the mandatory national cancer quality programme. They have been developed collaboratively by the North Cancer Alliance, South East Scotland Cancer Network, West of Scotland Cancer Network, Healthcare Improvement Scotland and PHS.

Further information

Access

The Cancer QPIs are located within the SCRIS dashboard, thus bringing all the cancer data together in the one place. Access to the Cancer QPIs dashboard is restricted and is accessible via. the User Access system.

Reports

For further information please refer to the West of Scotland Cancer (WoSCAN) and North Cancer Alliance (NCA) published reports.

Bladder Cancer Indicators

Definitions and details on updating or archiving Bladder Cancer indicators are available from Healthcare Improvement Scotland.

Cancer Quality Performance Indicators

PHS: Cancer Quality Performance Indicators

For more information on the National Cancer Quality Programme - Scottish Government letter CEL 06 2012.

The next release of this publication will be September 2024.